Cargando…

Age-Adjusted Charlson Comorbidity Index Scores as Predictor of Survival in Colorectal Cancer Patients Who Underwent Surgical Resection and Chemoradiation

We studied the effect of Age-Adjusted Comorbidity Index Score in colorectal cancer patients who underwent similarly aggressive treatment. Using the National Health Insurance Research Database of Taiwan, we identified 5643 patients with colorectal cancer who underwent surgical resection and chemoradi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chin-Chia, Hsu, Ta-Wen, Chang, Chun-Ming, Yu, Chia-Hui, Lee, Ching-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602551/ https://www.ncbi.nlm.nih.gov/pubmed/25590852 http://dx.doi.org/10.1097/MD.0000000000000431

Ejemplares similares

Age-adjusted charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection
por: Tian, Yaohua, et al.
Publicado: (2017)

Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery
por: Chang, Chun-Ming, et al.
Publicado: (2016)

Modified Tumor Classification With Inclusion of Tumor Characteristics Improves Discrimination and Prediction Accuracy in Oral and Hypopharyngeal Cancer Patients Who Underwent Surgery
por: Lee, Ching-Chih, et al.
Publicado: (2015)

Correction: Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery
por: Chang, Chun-Ming, et al.
Publicado: (2016)

Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival
por: Chang, Heng-Jui, et al.
Publicado: (2016)

Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection
por: Tian, Yaohua, et al.
Publicado: (2017)

Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer
por: Kim, Woo Ram, et al.
Publicado: (2015)

Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD
por: Ho, Chung-Han, et al.
Publicado: (2017)

Elevated Preoperative Serum Hs-CRP Level as a Prognostic Factor in Patients Who Underwent Resection for Hepatocellular Carcinoma
por: Liu, Yu-Bin, et al.
Publicado: (2015)

Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study
por: Yang, Ching-Chieh, et al.
Publicado: (2015)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

The prognosis of NX stage in patients with pT1 papillary thyroid cancer who underwent lobectomy
por: Ahn, Ha Rim, et al.
Publicado: (2023)

Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute
por: Jing, Wang, et al.
Publicado: (2016)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection
por: Kim, Do Hyoung, et al.
Publicado: (2021)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Charlson comorbidity index as a predictor of short-term outcomes after pulmonary resection
por: Shao, Weipeng, et al.
Publicado: (2020)

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Qu, Wei-Feng, et al.
Publicado: (2020)

The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients
por: Di Donato, Violante, et al.
Publicado: (2018)

An electronic application for rapidly calculating Charlson comorbidity score
por: Hall, William H, et al.
Publicado: (2004)

Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy
por: Huang, Long, et al.
Publicado: (2023)

Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma
por: Pan, Yu, et al.
Publicado: (2023)

Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries
por: Dessai, Sampada B., et al.
Publicado: (2018)

The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
por: Zhou, Shi, et al.
Publicado: (2022)

Impact of Age-Adjusted Charlson Comorbidity on Hospital Survival and Short-Term Outcome of Patients with Extracorporeal Cardiopulmonary Resuscitation
por: Tseng, Li-Jung, et al.
Publicado: (2018)

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
por: Lee, Sung Hwan, et al.
Publicado: (2015)

The association between the composite quality measure “textbook outcome” and long term survival in operated colon cancer
por: Yang, Ching-Chieh, et al.
Publicado: (2020)

Age-adjusted Charlson Comorbidity Index as effective predictor for in-hospital mortality of patients with cardiac arrest: a retrospective study
por: Zhang, Nan, et al.
Publicado: (2023)

Charlson Comorbidity Index and National Early Warning Score 2: Predictors of Mortality in COVID-19 Hospitalizations
por: Majzoub, Mariam, et al.
Publicado: (2022)

Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
por: Barz, Melanie, et al.
Publicado: (2022)

The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
por: Wang, Zhe, et al.
Publicado: (2023)

Recalibration and validation of the Charlson Comorbidity Index in acute kidney injury patients underwent continuous renal replacement therapy
por: Lee, Jinwoo, et al.
Publicado: (2022)

Charlson comorbidity index as a predictor of periodontal disease in elderly participants
por: Lee, Jae-Hong, et al.
Publicado: (2018)

Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices
por: Chen, Yu-Guang, et al.
Publicado: (2015)

Comparative effectiveness of simultaneous integrated boost vs sequential intensity-modulated radiotherapy for oropharyngeal or hypopharyngeal cancer patients: A population-based propensity score-matched analysis
por: Kuo, Yao-Hung, et al.
Publicado: (2019)

Efficacy and safety of chemoradiation therapy compared with chemotherapy for esophageal carcinoma: An updated meta-analysis of randomized controlled trials
por: Liu, Jinyuan, et al.
Publicado: (2017)

Argon plasma coagulation with atezolizumab and chemoradiation in lung pleomorphic cancer showed a remarkable response: Case report
por: Harada, Masanori, et al.
Publicado: (2021)

Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oadarueer1ij9ilsi74jmrr5v8